Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiodex: Dexmedetomidine in Cardiac Surgery
NCT03585452Completed
- Start
- Aug 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dexmedetomidine in Post-operative cognitive dysfunction (POCD) (2 arms). Primary endpoint: Cognitive function assessed by Addenbrooke's Cognitive Examination (ACE-III) at 3 months. Started Aug 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT03585452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03585452.